直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

Versata v. Rea - An APA Challenge to the AIA - Part 3

July 08, 2013

In this series, we follow Versata’s challenge under the Administrative Procedure Act (“APA”) to the USPTO’s implementation of the Transitional Program for Covered Business Method Patents, Section 18 of the AIA. Part 1 of this series examined Versata’s original complaint filed in the United States District Court for the Eastern District of Virginia, and Part 2 reviewed the agency’s motion to dismiss. Part 3 discusses Versata’s response, and Part 4 summarizes intervenor SAP’s arguments in support of dismissal.

Versata’s opposition to the USPTO’s motion to dismiss focuses on the APA’s presumption in favor of judicial review, and emphasizes that its challenge is directed to review of jurisdictional issues and not the merits of agency’s decision.

Versata asserts that 35 U.S.C. § 324(e) only precludes an appeal from the Director’s decision to institute a post-grant review, and not whether that decision is ultimately reviewable. But even if that were the case, Versata makes a textual argument that the unreviewable “determination” under § 324(e) is limited to decision’s substantive grounds and not the jurisdictional question, also relying on a similar interpretation for inter partes reexamination in Callaway Golf Co. v. Kappos, 802 F. Supp. 2d 678 (E.D. Va. 2011).

The opposition also cites the USPTO’s posting of the decision to institute the PGR to its website (“Representative Orders, Decisions, and Notices”) as evidence that the agency’s action was final, and thus subject to review under the APA. Versata also uses the posting to cast the decision as a rulemaking “designed to implement . . . law or policy,” rather than an interlocutory adjudication. In addition, Versata emphasizes the possibility that its $400 million damage award will be vacated to show an effect on its legal rights and obligations.

Finally, in the response to the agency’s position that the AIA provides an adequate remedy — an appeal to the Federal Circuit — Versata argues that because its jurisdictional claims were not considered in the PTAB’s final written decision, there is “no guarantee” that those claims would be reviewed on appeal. Thus, rather than “bet the farm” appealing the merits of the PTAB decision canceling its claims as unpatentable under 35 U.S.C. § 101, Versata argues that the APA’s presumption in favor of review should win out “where there is doubt concerning [an] alternative remedy.”

In Part 4, we examine the intervenor SAP’s arguments in support of dismissal.

Tags

35 U.S.C. § 101, Administrative Procedure Act (APA), Eastern District of Virginia, preclusion, software patents, United States Patent and Trademark Office (USPTO)

Copyright © 2013 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. Additional disclaimer information. 

Related Insights

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Charitable

Bridges From School to Work Gala 2026

June 22, 2026

Washington, DC

Charitable

Banding Together 2026

June 18, 2026

Washington, DC

Conference

2026 Copyright Society Annual Meeting

June 14-16, 2026

Louisville

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

Reception

12th Annual Georgia Asian Pacific American Bar Association Gala

May 21, 2026

Atlanta

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP